Offerings // X4 Pharmaceuticals, Inc

XFOR offering history

Every offering-related filing in X4 Pharmaceuticals, Inc’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 818 filings back to Sep 24, 2010.

Last executed offering

Oct 8, 2026

8-K — priced deal (shares or notes)

Last registration (announced)

May 6, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Oct 8, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 14, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 6, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Oct 24, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 23, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 18, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 17, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 10, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 13, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Aug 12, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 23, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 24, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 14, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jun 21, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 20, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 9, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 16, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Dec 9, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 7, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 5, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 5, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 29, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jul 29, 2022	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jul 1, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 13, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 22, 2022	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Mar 22, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 3, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 14, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 4, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 3, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 23, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 5, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jul 12, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jul 9, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 25, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Mar 19, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 26, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 19, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Oct 16, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)

XFOR offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full XFOR workspace →

XFOR offering FAQ

When did XFOR last execute an offering?

Per SEC filings, X4 Pharmaceuticals, Inc's most recent priced offering document is a 8-K filed 2026-10-08. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did XFOR last announce or register an offering?

The most recent registration is a S-3 filed 2026-05-06. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.